Log In
BCIQ
Print this Print this
 

foscarnet sodium

Also known as: Foscavir

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionCytomegalovirus (CMV) polymerase inhibitor
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationCytomegalovirus (CMV)
Indication DetailsTreat cytomegalovirus (CMV) infection
Regulatory Designation
PartnerClinigen Group plc;
Pfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1,700.0M

$1,700.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/03/2015

$1,700.0M

$1,700.0M

0

05/14/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today